filmov
tv
'Developing mRNA for therapy' - Dr. Katalin Karikó, 2022 Gairdner Laureate Lectures
Показать описание
Dr. Katalin Karikó is a 2022 Canada Gairdner International Award laureate for her pioneering work developing nucleoside-modified mRNA and lipid nanoparticle (LNP) drug delivery: the foundational technologies for the highly effective COVID-19 mRNA vaccines. She presented her award-winning research at the 2022 Gairdner Science Week Laureate Lectures.
0:28:52
'Developing mRNA for therapy' - Dr. Katalin Karikó, 2022 Gairdner Laureate Lectures
1:38:35
Development of mRNA for Therapy
0:32:34
Prof. Katalin Karikó「Developing mRNA for therapy」
1:15:45
Katalin Karikó: Developing mRNA for Therapy
0:00:06
Watch now! Developing mRNA for Therapy and COVID-19 Vaccine: The Story of an Immigrant
0:02:06
EXPERT - Developing mRNA Nanomedicines to Treat Cancer and Cardiovascular Disease
0:46:26
Development of mRNA and its Applications
0:01:24
How mRNA vaccines work
0:58:42
Quality by Design in mRNA Manufacturing
1:15:45
Scientist Stories: Katalin Karikó, Developing mRNA for Therapy
2:08:25
【Tang Prize Youth Symposium】Dr. Katalin Kariko’ - Developing mRNA for Therapy: My Journey
0:21:00
Translating mRNA-Based Medicines from Concept to Clinic
1:01:57
The Women in Science Webinar: Development of the mRNA Therapeutic- Not Warp Speed!
1:03:30
Panel: mRNA Process Development and Manufacturing on the Road to the Clinic
1:07:34
Challenges and Considerations for mRNA Therapeutic Development
0:14:53
Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
0:09:43
mRNA-based Therapeutics - Creative Biolabs
1:01:57
The Women in Science Webinar Development of the mRNA Therapeutic Not Warp Speed!
1:46:38
Development of mRNA vaccines and therapies
0:04:52
How mRNA Therapeutics Work
0:09:57
'Ionizable lipid nanoparticles advance translation of mRNA-based vaccines & therapy” - Gair...
0:16:04
Large-Scale Production of Plasmid DNA & mRNA to Support Therapeutic & Vaccine Development
0:01:03
How mRNA cancer vaccines work
0:16:57
Regulatory Concerns In mRNA Therapeutic Development
Комментарии